Infectious Diseases II
Learning Objectives
Compose a plan to incorporate quality metrics (e.g.,
prevention of catheter-associated urinary tract infec-
tions and catheter-related bloodstream infections)
into pre- and postsurgical care.
tools (including biomarkers and rapid diagnostic
tests) used by an antimicrobial stewardship team.
Provide empiric antibiotic therapy recommendations
for critically ill patients with community-acquired
or health careβassociated meningitis.
Evaluate therapeutic options for the treatment of
multidrug-resistant pathogens in the intensive care
unit (ICU).
Devise an optimal treatment plan for critically ill
immunocompromised patients with infectious dis-
eases.
American College of Surgeons National
Surgical Quality Improvement Program
ASP
Antibiotic stewardship program
Antimicrobial susceptibility testing
CAUTI
Catheter-associated urinary tract
infection
CDC
Centers for Disease Control and
Prevention
CLABSI
Central lineβassociated bloodstream
infection
CLSI
Clinical & Laboratory Standards Institute
CMS
Centers for Medicare & Medicaid
Services
CNS
Central nervous system
CoNS
Coagulase-negative Staphylococci
CRE
Carbapenem-resistant Enterobacterales
CSF
Cerebrospinal fluid
CVC
Central venous catheter
ESBL
Extended-spectrum Ξ²-lactamase
HAART
Highly active antiretroviral therapy
IDSA
Infectious Diseases Society of America
ICU
Intensive care unit
KPC
Klebsiella pneumoniae carbapenemase
LOS
Length of stay
| MALDI-TOF | Matrix-assisted laser desorption- |
|---|
ionization/time of flight
MIC
Minimum inhibitory concentration
MRSA
Methicillin-resistant Staphylococcus
aureus
MSSA
Methicillin-susceptible Staphylococcus
aureus
NHSN
National Healthcare Safety Network
OI
Opportunistic infection
PCR
Polymerase chain reaction
PCT
Procalcitonin
PD
Pharmacodynamic(s)
PK
Pharmacokinetic(s)
PNA FISH
Peptide nucleic acid fluorescence in situ
hybridization
SCIP
Surgical Care Improvement Project
SOT
Solid organ transplantation
SSI
Surgical site infection
TJC
The Joint Commission
UTI
Urinary tract infection
WHO
World Health Organization
Self-Assessment Questions
Answers and explanations to these questions can be
found at the end of this chapter.
A 56-year-old man (weight 140 kg) is scheduled to
have elective coronary artery bypass surgery with
aortic valve bioprosthetic replacement. The patient
has a medical history of diabetes and hypertension.
He has no drug allergies and has a calculated CrCl
of 90 mL/minute/1.73 m2. It is anticipated that the
patient will be admitted to the cardiovascular sur-
gery ICU after the surgery with two chest tubes
placed for drainage. Which is the most appropriate
antimicrobial prophylactic regimen for the patient?
sion and administered every 8 hours until chest
tubes are removed.
incision and administered every 12 hours until
48 hours after surgery.
sion, re-dosed if surgery lasts more than 4
hours, and continued for 48 hours after surgery.
re-dosed if surgery lasts more than 4 hours, and
continued for 48 hours after surgery.